Title: |
|
Estimating the Cost of Illness: The Case of Diabetes |
Description: |
|
We use the Medical Expenditure Panel Survey to estimate the direct medical costs of
diabetes. Separate estimates of the cost of diabetes are developed from an attributable
risk procedure and a two-part regression model. Costs include expenditures to treat
diabetes, chronic complications of the disease, and co-morbidities requiring additional
health care resources because the person is diabetic. The cost estimates range from $79.1
billion based on attributable risk to $88.8 billion based on the two-part regression model,
but the difference is not statistically significant. These estimates are derived from the
actual health care use and expenditure patterns of the disease population. They indicate
that 59 to 66 percent of health care spending by diabetics for physician and hospital care
and prescription medicines should be attributed to the disease itself. |
Author(s): |
|
Gary Olin, Steven R. Machlin and Jeffrey Rhoades |
Agency: |
|
Rockville (MD): Agency for Healthcare Research and Quality |
Back
Email Updates
